Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Celgene Corporation (NASDAQ:CELG): The stock has been upgraded by Deutsche Bank from Hold to Buy rating. The rating upgrade comes on the back of its Psoriasis drug candidate, Apremilast.
The therapy has shown positive results for its late stage trial. Deutsche analysts noted, “However, after a further survey of 100 dermatologists & rheumatologists, who suggest Apremilast is a blockbuster, we are encouraged.” The company expects to generate $1.5 billion worth of revenue from the drug in 2017. Celgene Corporation is currently trading at $115.83, down 0.52 percent from its previous close. The stock is trading below its 20 days moving average price of $115.88 and in line with its 50 days moving average price of $115.83. Its 52 weeks price range stands at $58.53 and $118.78. The stock is trading at the Price Earnings ratio of 35.11. Celgene Corporation commands market capitalization of $48.52 million. Celgene is up 49 percent in this year so far while its 52 weeks gain stands at 45.41 percent. Deutsche Bank also raised the price target for the stock to $143, up from $105.
Teradata Corporation (NYSE:TDC): Its stock traded in the range of $52.82 and $53.59 in the current trading session and at this point is at $52.89, down 0.86 percent. Stifel Nicolaus upgraded the stock from Hold to Buy. Teradata’s new price target stands at $63. It is currently trading near its 52 weeks low. The stock’s highest price point of 52 weeks stands at $80.97 while its lowest price point is at $50.40. Teradata Corporation stock is trading at Price Earnings ratio of 21.67 and its beta is 0.92. The company provides data mining technology solutions. The stock is likely to make bullish movement in the second half of the year. However, the company is likely to miss earnings guidance for the first quarter of the year. The stock has also been upgraded to Buy rating by Wellington Shields.
CenturyLink Inc. (NYSE:CTL): The stock is trading at $36.01, 0.28 percent lower than its previous close. It has traded in the range of $35.86 and $36.08 in the current trading session. CenturyLink is rated Overweight by JPMorgan Chase and its price target has been set at $38. The stock has traded 826,050 shares so far, in comparison to its daily average trading volume of 6.25 million shares. The stock has traded in the range of $32.05 and $43.43 in the past 52 weeks. The company stock trades at Price Earnings ratio of 28.87 and its beta is at 0.68. CenturyLink has robust dividend yield of 6 percent. The company is scheduled to announce its first quarter earnings on May 8th. It offers integrated telecommunication services and is operational globally. CenturyLink is based out of Louisiana and was established in 1968.
Dollar Tree Inc. (NASDAQ:DLTR): the stock has been upgraded from equalweight to overweight by Morgan Stanley. The research firm noted, “Lower income shoppers were least aware of the tax change. This removes much of the bear case risk of a collapse of the lower income consumer.” Its price target has been set at $57. The company stock is currently trading at $46.66, down 0.72 percent from its previous close. The stock had opened at $47.06 and has traded in the range of $46.53 and $47.38 in the current trading session. It has traded 473,019 shares as of now. Dollar Tree Inc. commands market capitalization of $10.48 billion and its Price Earnings ratio is 17.33. Dollar Tree runs discount variety stores and is operational in the United States and Canada. The company is based out of Virginia.
Brinker International (NYSE:EAT): It is currently trading at $38.20, down 0.73 percent. It is trading in the range of $38.05 and $38.68 in the current trading session, which is also its 52 weeks high. The stock is lower than its 20 days moving average price of $38.43 and 50 days moving average price of $38.41. Brinker International has been upgraded by Goldman Sachs. It is now graded Buy, up from its previous rating of Neutral. The stock’s new price target has been set at $44. Its previous price target was $37. In the past 52 weeks, the stock’s price range has been $26.50 and $38.69. The stock’s beta is 1.45 and its Price Earnings ratio is 18.79. Brinker International commands market capitalization of $2.71 billion.
